Skip to main content

Advertisement

SpringerLink
Log in

Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kotla V, Goel S, Nischal S, Heuck C, Vivek K, Das B et al (2009) Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol 2:36

    Article  Google Scholar 

  2. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY (2018) Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol 154:461–466

    Article  Google Scholar 

  3. Wang JY, French LE, Shear NH, Amiri A, Alavi A (2018) Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol 19:67–77

    Article  Google Scholar 

  4. Hu YQ, Yao XX, Zhang JZ, Li WH (2019) Penile pyoderma gangrenosum: successful treatment with thalidomide. Dermatol Ther 32(4):e12952

  5. Dasanu CA, Alexandrescu DT (2009) A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. Eur J Haematol 82:231–234

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Hematology, CHU Grenoble Alpes, Grenoble, France

    Mathieu Meunier, Mathilde Schacherer, Clémence Deteix, Stéphane Courby & Jean Yves Cahn

  2. CNRS UMR 5309, INSERM, U1209, Institute for Advanced Bioscience, Université Grenoble Alpes, 38700, Grenoble, France

    Mathieu Meunier

  3. Department of Clinical Pharmacology, CHU Grenoble Alpes, Grenoble, France

    Ayoub Larabi

Authors
  1. Mathieu Meunier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayoub Larabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mathilde Schacherer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Clémence Deteix
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stéphane Courby
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean Yves Cahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors participated in the conception, writing, revising, and approval of the manuscript.

Corresponding author

Correspondence to Mathieu Meunier.

Ethics declarations

Conflict of interest

The authors declare no major conflict of interest.

Statement of informed consent

Procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meunier, M., Larabi, A., Schacherer, M. et al. Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma. Ann Hematol 99, 379–380 (2020). https://doi.org/10.1007/s00277-019-03846-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03846-0

Search

Navigation